LS-C98476

antibody from LSBio

Targeting: EZH1 KIAA0388, KMT6B

Western blot

Antibody data

Submit

Validation data

Product number: LS-C98476 - Provider product page
Provider: LSBio
Proper citation: LifeSpan Cat#LS-C98476, RRID:AB_2262595
Product name: EZH1 / ENX-2 Antibody (aa393-422) LS-C98476
Antibody type: Polyclonal
Description: Ammonium sulfate precipitation
Reactivity: Human
Host: Rabbit
Storage: Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.

EZH1 protein structure - LS-C98476 shown in red.

Enhanced validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Enhanced validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human prostate carcinoma tissue reacted with EZH1 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human prostate carcinoma tissue reacted with EZH1 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.